Back

Accretion Pharmaceuticals Ltd

IPO Details · GMP · Subscription · Financials

✅ Listed NSE SME SME Live Chart
Issue Price
₹101
Per Share
GMP
NIL
Grey Market
Est. Listing
₹101
Expected Price
Min. Application
₹242,400
2 lots × 1200 shares
IPO Issue Details
Issue Price / Price Band₹101 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size1,200 Shares per Lot
Total Issue Size29,46,000 shares (aggregating up to ₹29.75 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformNSE SME
IPO TypeSME
Subscription OpenWed, 14 May 2025
Subscription CloseFri, 16 May 2025
Anchor AllotmentTue, 13 May 2025
Basis of AllotmentMon, 19 May 2025
Initiation of RefundsTue, 20 May 2025
Credit of Shares to DematMon, 19 May 2025
Listing DateWed, 21 May 2025
UPI Mandate Deadline5:00 PM on 16 May 2025 (Day 3)
Application & Investment Details
Retail — Min (1 Lots)₹1,21,200 — 1200 shares
Retail — Max (13 Lots)₹1,575,600 (13 Lots)
HNI — Min (2 Lots)₹2,42,400 — 2,400 shares
EPS (Pre-IPO)₹4.74
EPS (Post-IPO)₹6.28
P/E Ratio (Pre-IPO)21.29x
P/E Ratio (Post-IPO)16.08x
Net Offer to Public27,98,400 shares (aggregating up to ₹28.26 Cr)
Reserved for Market Maker1,47,600 shares (aggregating up to ₹1.49 Cr)
Pre-IPO Promoter Holding81,70,000 shares
Post-IPO Promoter Holding1,11,16,000 shares
About Accretion Pharmaceuticals Ltd

Incorporated in 2012, Accretion Pharmaceuticals Limited is a pharmaceutical company that manufactures and sells tablets, capsules, and other healthcare products.The company also offers contract manufacturing services. The Company manufactures and markets Tablets, Capsules, Oral Liquids, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), and Oral Powder (Sachet, Dry Syrup).The company also holds ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005 certifications, reflecting its dedication to quality and environmental management systems.The company's manufacturing unit is located in Ahmedabad, Sanand, Gujarat.The company has expanded its global footprint, marking its presence in more than 20 countries, including regions in Africa, Southeast Asia, and the Middle East.Product Portfolio and ServicesTablets and Capsules – Covering antibiotics, anti-inflammatory, pain management, cardiovascular, and gastrointestinal medicines.Oral Liquids and Syrups – Used for respiratory, pediatric, and digestive treatments.External Preparations – Including medicated lotions, gels, ointments, and dusting powders for skin care and dermatological treatments.Ayurvedic and Herbal Products – Focused on natural wellness solutions for immunity, digestion, and general health.As of January 2025, the company has 83 employees (including 4 Executive Directors) on its payroll.Competitive Strength:Experienced Promoters and Management Team.Long-standing relationship with clients and suppliers.Focus on providing quality products.Management has built a supply chain and customer relations, creating goodwill and trust.

Objects of the Issue

Accretion Pharmaceuticals Ltd proposes to utilise the net proceeds from the Issue for the following objects:

1
Capital expenditure towards purchase of new equipment/ machineries, etc.
2.70
2
Capital expenditure towards upgradation of existing manufacturing facility
4.66
3
Repayment/prepayme nt of certain borrowings availed by the Company
0.99
4
Funding working capital requirements
14.68
5
General Corporate Purpose
4.43
Shareholding & Lock-in
Pre-IPO Promoter Holding 81,70,000 shares
Post-IPO Promoter Holding 1,11,16,000 shares
Check AllotmentCheck Status →
Accretion Pharmaceuticals Ltd — Live Price LIVE
₹101.00
INR · NSE
Fetching live data…
VS Issue Price
OPEN
HIGH
LOW
MKT CAP
P/E
52W HIGH
52W LOW
VOLUME
DIVIDEND
DIV YIELD
Loading chart…
Chart Not Available
Accretion Pharmaceuticals Ltd is not yet listed on Yahoo Finance or has a different ticker symbol.
Try again after listing stabilises (2-3 trading days).
Issue ₹101.00 Live Price
Quick Facts
GMP Signal ⚪ No GMP
StatusListed
Issue Price₹101
GMPNIL
Est. Listing₹101
Lot Size1,200 shares
Min Amount₹242,400
Listing Date21 May 2025
Disclaimer: GMP is unofficial and unregulated. It does not guarantee actual listing price.
Listing Performance
Issue Price₹101
Listing Date21 May 2025
Listing Price
Listing Gain/Loss—%
52-Week High
52-Week Low
Issue Structure & Reservation
Category Shares Offered % Issue Amount (₹ Cr)* Subscription
Market Maker 147,600 ₹1.49 Cr
TOTAL 2,946,000 100.00% ₹29.75 Cr
* Based on ₹101.00 (upper price band)
Lot Size & Investment Details
Lot Size
1,200
Shares
Issue Price
₹101.00
Per Share
Min Investment
₹121,200
1 Lot
Category Lots Shares Amount (₹)
Retail (Min) 1 1,200 ₹121,200
Retail (Max) 13 15,600 ₹1,575,600
sNII (Min) 14 16,800 ₹1,696,800
bNII (Min) 68 81,600 ₹8,241,600
Company Financials — Restated Consolidated (Amount in ₹ Crore)
Particulars31 Dec 202431 Mar 202431 Mar 2023
Revenue from Operations 35.75 33.94 29.53
EBITDA N/A N/A N/A
Profit After Tax (PAT) 5.24 3.88 0.10
Net Worth 13.58 5.35 3.84
Total Assets 39.99 27.05 20.58
Reserves & Surplus 5.41 1.35 0.00
Total Borrowings 13.79 13.48 8.47
Key Ratios & Valuation
Issue Price ₹101
Face Value ₹10 Per Share
P/BV 7.55
RoE 72.47%
RoCE 36.73%
RoNW 72.47%
PAT Margin (%) 11.51%
EBITDA Margin (%) N/A
Debt / Equity 2.52
Company Details
Company
Accretion Pharmaceuticals Ltd
Exchange
NSE SME
IPO Type
SME IPO
Issue Type
Bookbuilding IPO
Face Value
₹10 Per Share
Script Code
N/A
Address
29 Xcelon Ind Park 1, B/h, Intas Pharmaceuticals, Vasna Chacharvad Sanand, Ahmedabad, Gujarat, 382213
Book Running Lead Managers
Jawa Capital Services Pvt.Ltd
Book Running Lead Manager (BRLM)